In the adenocarcinoma study, from 230 samples, 17.8% of the cases (41/230) presented genetic alterations of hCAR, including Copy Number Alterations (CNA), mutations or altered gene expression (Fig. 4). Here, CXADR is linked to adenocarcinoma.